logo

Inovio Pharmaceuticals Inc: Navigating a Turbulent Year, Up -19.09% from 52-Week Low

CSCO Stock

The market performance of Inovio Pharmaceuticals Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $14.88 on 03/13/23, while the lowest value for the same duration was $3.89 on 11/10/23.

52-week price history of INO Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Inovio Pharmaceuticals Inc’s current trading price is -19.09% away from its 52-week high, while its distance from the 52-week low is 209.67%. The stock’s price range during this period has spanned from $3.89 to $14.88. In the Healthcare sector, the Inovio Pharmaceuticals Inc’s shares surpassed a trading volume of approximately 1.82 million for the day, which was noticeably higher compared to the average daily volume of 9.0.47 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Inovio Pharmaceuticals Inc (INO) has experienced a quarterly rise of 165.43% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 281.37M and boasts a workforce of 122 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 6.29, with a change in price of +5.82. Similarly, Inovio Pharmaceuticals Inc recorded 379,195 in trading volume during the last 100 days, posting a change of +93.69%.

Examining INO’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for INO stands at 0.26. Similarly, the long-term debt-to-equity ratio is also 0.09.

INO Stock Stochastic Average

Today’s raw stochastic average for Inovio Pharmaceuticals Inc over the last 50 days is 90.69%.This indicates a increase from the raw stochastic average of the past 20 days, which was 88.04%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 83.55% and 84.95%, respectively.

INO Stock Price Performance Analysis

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The metric has seen a significant gain of 96.73% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 121.98%. Over the past 30 days, the price of INO has fallen by 109.76%. And in the last five days, it has surged by 22.61%.